Trials / Completed
CompletedNCT00758758
Performance of the Hedrocel(R) Cervical Fusion Device
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 231 (actual)
- Sponsor
- Zimmer Biomet · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this clinical investigation is to compare patients treated with Anterior Cervical Discectomy and Fusion (ACDF) using the Hedrocel Cervical Fusion Device, with a concurrent, randomized, control group receiving autologous iliac crest bone graft or allograft and test the hypothesis that ACDF with Hedrocel is non-inferior to ACDF with allograft or autologous bone graft.
Detailed description
The objective of this clinical investigation is to compare patients treated with Anterior Cervical Discectomy and Fusion (ACDF) using the Hedrocel Cervical Fusion Device, with a concurrent, randomized, control group receiving autologous iliac crest bone graft. Success criteria include radiographic evidence of fusion, and improvement in pain, function and overall quality of life. If shown to be successful, the use of the Hedrocel Cervical Fusion Device would eliminate complications associated with harvesting autologous bone graft and provide an alternative for those who are unable to provide autologous bone graft from the iliac crest.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Anterior Cervical Discectomy and Fusion | Implantation of Hedrocel |
| DEVICE | Anterior Cervical Discectomy and Fusion | Implantation of Allograft |
| DEVICE | Anterior Cervical Discectomy and Fusion | Implantation of Autograft |
Timeline
- Start date
- 2001-12-01
- Primary completion
- 2009-01-01
- Completion
- 2009-06-01
- First posted
- 2008-09-25
- Last updated
- 2013-08-23
- Results posted
- 2013-08-12
Locations
13 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00758758. Inclusion in this directory is not an endorsement.